According to our (Global Info Research) latest study, the global Guanidinoacetic Acid market size was valued at US$ 37.6 million in 2024 and is forecast to a readjusted size of USD 49.4 million by 2031 with a CAGR of 4.0% during review period.
Guanidinoacetic Acid is a metabolite of glycine in which the amino group has been converted into a guanidine. Guanidinoacetic Acid is a direct precursor of creatine and is used as a supplement. Taking guanidinoacetic acid can increase muscle strength and slow muscle fatigue, etc. And add guanidinoacetic acid into fodder can make lean pig"s body improve significantly.
However the metabolism of creatine from Guanidinoacetic Acid in the liver causes a depletion of methyl groups. This causes homocysteine levels to rise, which has been shown to produce cardiovascular and skeletal problems. A series of studies showed that a combination of betaine and Guanidinoacetic Acid improves the symptoms of patients with chronic illness, including heart disease, without toxicity. Betaine can provide a methyl group to glycocyamine, via methionine, for the formation of creatine. In overall, such treatment led to less fatigue, greater strength and endurance, and an improved sense of well-being. The patients with cardiac decompensation (arteriosclerosis or rheumatic disease) and congestive heart failure had improved cardiac function. The patients gained weight (improved nitrogen balance) and saw lessened symptoms of arthritis and asthma and increased libido, and those people suffering from hypertension experienced transient reduced blood pressure. Also the studies shows the increase of glucose tolerance in both diabetic subjects and subjects without diabetes.
The main market players are Evonik, Tiancheng Chempharm, Jiangsu Yuanyang, Hubei Yuanhua, Hebei Daxiao and GENDONE, with about 50% market shares.
This report is a detailed and comprehensive analysis for global Guanidinoacetic Acid market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Guanidinoacetic Acid market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Guanidinoacetic Acid market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Guanidinoacetic Acid market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
Global Guanidinoacetic Acid market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Guanidinoacetic Acid
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Guanidinoacetic Acid market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Evonik, Tiancheng Chempharm, Jiangsu Yuanyang, Hubei Yuanhua, Hebei Daxiao, GENDONE, Shijiazhuang Zexing Group, Lubon Industry, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Guanidinoacetic Acid market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Feed Grade
Pharmaceutical Grade
Others
Market segment by Application
Fodder
Medicine
Others
Major players covered
Evonik
Tiancheng Chempharm
Jiangsu Yuanyang
Hubei Yuanhua
Hebei Daxiao
GENDONE
Shijiazhuang Zexing Group
Lubon Industry
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Guanidinoacetic Acid product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Guanidinoacetic Acid, with price, sales quantity, revenue, and global market share of Guanidinoacetic Acid from 2020 to 2025.
Chapter 3, the Guanidinoacetic Acid competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Guanidinoacetic Acid breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Guanidinoacetic Acid market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Guanidinoacetic Acid.
Chapter 14 and 15, to describe Guanidinoacetic Acid sales channel, distributors, customers, research findings and conclusion.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook